Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate Physician Awareness and Knowledge of Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Monotherapies in Europe: an Observational Post-Authorisation Joint Safety Study (Safe-CAM)

NCT04925180 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04925180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04925180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate Physician Awareness and Knowledge of Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Monotherapies in Europe: an Observational Post-Authorisation Joint Safety Study (Safe-CAM)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 18, 2021
Completion date
December 31, 2021
Enrollment
600 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypersexuality in men, prostate cancer, sexual deviations in men, signs of androgenisation in women, e.g. hirsutism, androgenetic alopecia, acne and seborrhea